2
TITLE: Covalent Histone Modification by an Electrophilic Derivative of the Anti-HIV Drug Nevirapine  Full Text
AUTHORS: Harjivan, SG; Charneira, C; Martins, IL; Pereira, SA; Espadas, G; Sabido, E; Beland, FA; Marques, MM; Antunes, AMM;
PUBLISHED: 2021, SOURCE: MOLECULES, VOLUME: 26, ISSUE: 5
INDEXED IN: Scopus WOS
3
TITLE: Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds  Full Text
AUTHORS: Andre Campanico; Shrika G Harjivan; Digby F Warner; Rui Moreira; Francisca Lopes;
PUBLISHED: 2020, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 21, ISSUE: 22
INDEXED IN: WOS
7
TITLE: First in vitro evidence for a catechol metabolite from the anti-HIV drug efavirenz - A plausible role in toxicity  Full Text
AUTHORS: Harjivan, SG; Wanke, R; Woodling, K; Gamboa da Costa, GG; Beland, FA; Antunes, AMM; Marques, MM;
PUBLISHED: 2015, SOURCE: 51st Congress of the European-Societies-of-Toxicology (EUROTOX) in TOXICOLOGY LETTERS, VOLUME: 238, ISSUE: 2
INDEXED IN: WOS CrossRef
9
TITLE: The phenolic metabolites of the anti-HIV drug efavirenz: Evidence for distinct reactivities upon oxidation with Fremy's salt  Full Text
AUTHORS: Shrika G Harjivan; Riccardo Wanke; Joao L F Ferreira da Silva; Matilde Marques, MM ; Alexandra M M Antunes;
PUBLISHED: 2014, SOURCE: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, VOLUME: 74
INDEXED IN: Scopus WOS CrossRef
10
TITLE: Covalent histone modification by nevirapine: Potential association with non-AIDS defining cancers
AUTHORS: Shrika G Harjivan; Catarina Charneira; Sofia A Pereira; Guadalupe Espadas; Eduard Sabido; Frederick A Beland; Matilde Marques, MM; Alexandra M M Antunes;
PUBLISHED: 2014, SOURCE: 248th National Meeting of the American-Chemical-Society (ACS) in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, VOLUME: 248
INDEXED IN: WOS
Page 1 of 2. Total results: 20.